Abstract
This paper briefly considers some of the perceived problems associated with the exclusive rights model of patent management in biotechnology. It then goes on to explore the range of legal options for dealing with some of these perceived problems, together with alternative co-operative approaches that are currently under discussion in various forums, including open access models. This review shows that there are many parallels in the issues currently being debated in the information technology and biotechnology industries in relation to the copyright and patent regimes of intellectual property.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
